openPR Logo
Press release

Inflammatory Bowel Disease Treatment Market Key Trends And Strategies For Expansion 2024-2033

11-25-2024 07:46 AM CET | Health & Medicine

Press release from: The Business Research Company

Inflammatory Bowel Disease Treatment Market Key Trends

Inflammatory Bowel Disease Treatment Market Key Trends

"The Business Research Company recently released a comprehensive report on the Global Inflammatory Bowel Disease Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

According to The Business Research Company's, The inflammatory bowel disease treatment market size has grown strongly in recent years. It will grow from $23.49 billion in 2023 to $25.56 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increased prevalence of inflammatory bowel disease, growing demand for biologics and immunomodulators, advancements in treatment options, rising geriatric population, increased awareness about the disease.

The inflammatory bowel disease treatment market size is expected to see strong growth in the next few years. It will grow to $36.63 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing investment in research and development activities, growing demand for biosimilars, rising incidence of inflammatory bowel disease in emerging markets, growing demand for personalized medicine, integration of precision medicine in ibd treatment. Major trends in the forecast period include increasing number of product launches and approvals, personalized dosing and treatment plans in ibd management, use of telemedicine for remote monitoring of ibd patients, exploration of microbiome-based therapies for ibd, adoption of value-based care models in ibd treatmen.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Market Drivers and Trends:

The rising prevalence of Crohn's disease and ulcerative colitis is significantly driving the inflammatory bowel disease treatment market. Crohn's disease and ulcerative colitis are types of inflammatory bowel diseases (IBD) that cause inflammation and ulcers (sores) in the digestive tracts. The rising cases of Crohn's disease and ulcerative colitis are expected to boost demand for inflammatory bowel disease treatments, as they are widely used to reduce bowel inflammation and reduce and prevent medical complications. For instance, according to March 2022 research published in the United States National Library of Medicine, a US-based medical library, around 1.6 million Americans currently suffer from inflammatory bowel disease (Crohn's disease or ulcerative colitis) and around 70,000 new cases of IBD are diagnosed every year in the USA. Hence, the rising prevalence of Crohn's disease and ulcerative colitis is expected to drive the inflammatory bowel disease treatment market growth.

Product innovations have emerged as the key trend gaining popularity in the 5G chipset market. The major players in the market are developing innovative products for market growth. For instance, in June 2021, Samsung Electronics, a South Korea-based electronics company, developed 3GPP Rel.16 compliant chipsets, a range of next-generation 5G chipsets that deliver cutting-edge 5G technologies. The new chipsets consist of a second-generation 5G modem System-on-Chip (SoC), a third-generation mmWave Radio Frequency Integrated Circuit (RFIC) chip, and a Digital Front End (DFE)-RFIC integrated chip. These are designed to increase power efficiency, boost performance, and reduce the size of 5G solutions.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Union Chimique Belge S. A., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic - Gastroenterology West P. C., Ebony 60 Inc., Salix Pharmaceuticals Inc., Shire plc, Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

Inflammatory Bowel Disease Treatment Market 2024 Key Insights:

• The inflammatory bowel disease treatment market size is expected to see strong growth in the next few years. It will grow to $36.63 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.
• The Surge In Inflammatory Bowel Diseases Spurs Growth In Treatment Market
• Embracing Technological Advancements In Inflammatory Bowel Disease Treatment
• North America was the largest region in the inflammatory bowel disease treatment market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=6704&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammatory Bowel Disease Treatment Market Key Trends And Strategies For Expansion 2024-2033 here

News-ID: 3753304 • Views:

More Releases from The Business Research Company

Non-Invasive Ventilators Market: Major Trends Reshaping the Future of the Industry
Non-Invasive Ventilators Market: Major Trends Reshaping the Future of the Indust …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Non-Invasive Ventilators Industry Market Size Be by 2025? The market size for non-invasive ventilators has seen consistent growth over the past few years. The market value is projected to increase from $2.91 billion in 2024 to $3.05 billion in 2025, reflecting a compound annual growth rate
The Impact Of Increasing Chronic Disease Incidence On The Mobile C-Arm Market: A Key Catalyst Accelerating Mobile C-arm Market Growth in 2025
The Impact Of Increasing Chronic Disease Incidence On The Mobile C-Arm Market: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Mobile C-arm Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size of the mobile c-arm has seen consistent growth in the recent past. The market value is projected to increase from $1.36 billion in 2024 to a higher $1.42 billion in 2025, with
Lithotripsy Devices Market Expected to Achieve 5.4% CAGR by 2029: Growth Forecast Insights
Lithotripsy Devices Market Expected to Achieve 5.4% CAGR by 2029: Growth Forecas …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Lithotripsy Devices Market Size By 2025? In the past few years, the market size for lithotripsy devices has seen a steady increase. The forecasted growth is from $1.25 billion in 2024 to $1.3 billion in 2025, maintaining a compound annual growth rate (CAGR) of 4.2%.
Top Trends Transforming the Laparoscopy Devices Market Landscape in 2025: New Advanced Energy Device Enhances Precision And Efficiency In Open Surgical Procedures
Top Trends Transforming the Laparoscopy Devices Market Landscape in 2025: New Ad …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Laparoscopy Devices Industry Market Size Be by 2025? In recent years, the market size for laparoscopy devices has seen impressive growth. It is predicted to expand from $12.75 billion in 2024 to $13.49 billion in 2025, with a compound annual growth rate (CAGR) of 5.8%. This

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and